ZTS (Zoetis Inc.) Expected net earnings per share growth this year

Corporate emblem and logo of zoetis.com (ZTS)

High regulatory barriers and patent protection securely shield the Zoetis Inc. (ZTS) business from new entrants. Dominance in this niche allows for the effective scaling of sales while keeping operating expenses under control. Revenues are based on the sale of veterinary vaccines and medications for livestock and pets. Annual EPS progress reflects market sentiment, where -1.60 serves as the base value of the parameter.

ZTS - Zoetis Corp Earnings growth in current year over the range 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Zoetis Inc. (ZTS)

- business market valuation indicators:
Summary company analysis:Zoetis Corporation - ZTS
Mass-produced product of Zoetis Corporation

The stability of the workforce at Zoetis Inc. (ZTS), underpinned by the high qualifications of its veterinarians and the attractiveness of the sector, is directly reflected in the YoY net income per share dynamics. This indicator measures the annual EPS growth rate by calculating the difference between the current and previous periods, allowing investors to assess the real efficiency of business scaling and its resilience to market shocks.